Purpose
To explore the effect of milk fat globule-epidermal growth factor 8 (MFG-E8)
on sepsis-induced acute kidney injury (SAKI).
Methods
Male C57BL/6 mice were randomized to control, sham, CLP, CLP+PBS, and
CLP+rmMFG-E8 groups. SAKI was induced by cecal ligation and puncture (CLP).
Recombinant mouse MFG-E8 (rmMFG-E8) (20 μg/kg) or PBS (vehicle) was
administered intraperitoneally. Blood, urine and renal tissue were collected
at 24 h after CLP. Blood samples were tested for serum kidney injury
biomarker and cytokines. Urine samples were collected to detect KIM-1, and
NGAL. Real-time PCR was tested for Bax and Bcl-2. TUNEL staining was used to
determine renal apoptosis. Western blot was used to detect the expression of
Bax, Bcl-2, and proteins in the NF-κB pathway.
Results
MFG-E8 alleviated SAKI by decreasing serum Cre, BUN, urine KIM-1 and NGAL
and by mitigating renal pathological changes significant (p < 0.05).
IL-1β, IL-6, TNF-α were significantly inhibited by MFG-E8 (p < 0.05).
Apoptosis induced by SAKI was markedly suppressed by MFG-E8. Finally, MFG-E8
attenuated the activation of the NF-𝜅B signaling pathway in SAKI.
Conclusion
MFG-E8 has beneficial effects on SAKI, which may be achieved by inhibiting
the NF-κB pathway.